Journal of Translational Medicine · 2024 · 35 citations · 96 references
Veterinary MedicinePathobiologySurgeryCell TherapyCellular PathologyInflammationEsophageal DiseasesEsophageal SurgeryFibrosisMucosal Barrier FunctionMucosal InflammationMucosal PermeabilityEpithelial Barrier DamageEpithelial Barrier FormationEpithelial Barrier PermeabilityEsophageal Mucosal InjuryEsophageal PathologyEsophageal Stricture ManagementStricture PathophysiologyTissue-engineered Constructs
BACKGROUND: Esophageal strictures significantly impair patient quality of life and present a therapeutic challenge, particularly due to the high recurrence post-ESD/EMR. Current treatments manage symptoms rather than addressing the disease's etiology. This review concentrates on the mechanisms of esophageal stricture formation and recurrence, seeking to highlight areas for potential therapeutic intervention. METHODS: A literature search was conducted through PUBMED using search terms: esophageal stricture, mucosal resection, submucosal dissection. Relevant articles were identified through manual review with reference lists reviewed for additional articles. RESULTS: Preclinical studies and data from animal studies suggest that the mechanisms that may lead to esophageal stricture include overdifferentiation of fibroblasts, inflammatory response that is not healed in time, impaired epithelial barrier function, and multimethod factors leading to it. Dysfunction of the epithelial barrier may be the initiating mechanism for esophageal stricture. Achieving perfect in-epithelialization by tissue-engineered fabrication of cell patches has been shown to be effective in the treatment and prevention of esophageal strictures. CONCLUSION: The development of esophageal stricture involves three stages: structural damage to the esophageal epithelial barrier (EEB), chronic inflammation, and severe fibrosis, in which dysfunction or damage to the EEB is the initiating mechanism leading to esophageal stricture. Re-epithelialization is essential for the treatment and prevention of esophageal stricture. This information will help clinicians or scientists to develop effective techniques to treat esophageal stricture in the future.
96
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text
Endoscopic Submucosal Dissection of Early Esophageal Cancer
Tsuneo Oyama, Akihisa Tomori, Kinichi Hotta et al. · Clinical Gastroenterology and Hepatology · 2005 · 608 citations